Key facts
- Notable investors include CAS Star, Addor Capital, Innoangel Fund, Goldport Capital, Suzhou Nachuan Investment Management — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Xiangsheng New Materials
- ·The full record, as it builds
Funding rounds
No funding rounds for Xiangsheng New Materials are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Xiangsheng New Materials
Developer of biochemical products designed for biomaterials. The company's products primarily focus on research and development in biochemical product technology, bio-based material technology, bio-based material polymerisation technology, and industrial enzyme preparation, thereby providing customers with reliable and innovative products.
- Sector
- Healthcare
- HQ
- Shenzhen, China
- Founded
- 2024
- Ownership
- Privately Held (backing)
Xiangsheng New Materials doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Xiangsheng New Materials shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Xiangsheng New Materials in its N-PORT filings yet. We sweep new filings monthly.